Login / Signup
Editorial: calcineurin inhibitors as a bridge to vedolizumab for severe ulcerative colitis.
Robert Battat
Published in:
Alimentary pharmacology & therapeutics (2020)
Keyphrases
</>
ulcerative colitis
early onset